Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Gossamer Bio (NASDAQ: GOSS) Sets September 10 Effective Time For Share Split

Gossamer Bio, Inc. (NASDAQ: GOSS) plans to reduce its authorized common shares from 4,000,000,000 to 50,000,000 as part of a reverse stock split and related capital-stock reduction. The measure is intended to help the biotechnology company regain compliance with Nasdaq’s minimum bid-price requirement, with …

Vinay Lochav | 10 September 2026

IQVIA (NYSE: IQV) Plans $2B Senior Notes Offering to Refinance Debt

IQVIA HOLDINGS INC. (NYSE: IQV) is pursuing $2,000,000,000 of senior notes due 2034, giving itsWholly Owned SubsidiaryIQVIA Inc. a new long-datedDebtinstrument. The proceeds are designated for debt repayment and offering-related fees and expenses.

Vinay Lochav | 10 September 2026

Kura Oncology (NASDAQ: KURA) Retains 49.2% Caspian Stake After $50M Raise

Kura Oncology, Inc. (NASDAQ: KURA) created Caspian Therapeutics to develop next-generation menin inhibitors for diabetes and other cardiometabolic diseases. Caspian raised $50.0 million through the sale of Series A preferred stock, while Kura invested $4.3 million in the financing.

Vinay Lochav | 10 September 2026

KYNTRA BIO (NASDAQ: KYNB) CEO Holds 26,796 Shares After Forfeiture

KYNTRA BIO, INC. (NASDAQ: KYNB) CEO Wettig Thane forfeited 209 shares at $8.55 per share. Following the transaction, his reported ownership stood at 26,796 shares.

Vinay Lochav | 10 September 2026

Chemomab Therapeutics (NASDAQ: CMMB) HBM Elects Warrant Exercise for 12.5% Stake

HBM Healthcare Investments (Cayman) Ltd. reports beneficial ownership of 80,971,680 ordinary shares in Chemomab Therapeutics Ltd. (NASDAQ: CMMB), representing 12.5% of the company’s ordinary shares.

Vinay Lochav | 10 September 2026

Clinuvel (NASDAQ: CUVL) Targets FDA 510(k) Route for ZEROKIN Administration Device

The device is intended for formulations developed through the company’s research, development and innovation activities in Singapore.

Vinay Lochav | 10 September 2026

CYBIN INC. (NASDAQ: HELP) Reports 4,370,278 Shares Under Sole Authority

CYBIN INC. (NASDAQ: HELP) reported Eric So’s 5.8% beneficial ownership, including 105,264 common shares underlying warrants. So purchased 95,000 common shares on September 1, 2026, for $1,121,475. CYBIN INC. Also awarded him 1,046,899 restricted stock units.

Vinay Lochav | 10 September 2026

Denali Therapeutics Insider Sells 1,654 Shares at $22.29 (NASDAQ: DNLI)

Denali Therapeutics Inc. (NASDAQ: DNLI) Chief Medical Officer Chin Peter Scott sold 1,654 shares at $22.29 per share. The transaction occurred on 4 September 2026.

Vinay Lochav | 10 September 2026

Editas Medicine (NASDAQ: EDIT) Records Sept. 8 Award to Ory Daniel Scott

Editas Medicine, Inc. (NASDAQ: EDIT) awarded 950,000 derivative securities to Ory Daniel Scott, its executive vice president and chief medical officer. The transaction was recorded on 8 September 2026. Scott’s resulting derivative-securities holding was also 950,000.

Vinay Lochav | 10 September 2026
Support

Hi! How can we help you today?

Loading…